Low Iron Stores in Otherwise Healthy Children Affect Electrocardiographic Markers of Important Cardiac Events
- 306 Downloads
Both an excess of iron and iron deficiency (ID) may lead to significant cardiac problems. Parameters that represent ventricular repolarization heterogeneity, like QT dispersion (QTd), corrected QT dispersion (QTcd), the interval between the peak and the end of the T wave (Tp-e), and Tp-e dispersion, have not been evaluated in otherwise healthy children with low iron levels before. Here we assessed the effects of low iron storage on P wave dispersion (PWd), QTd, Tp-e intervals, and Tp-e dispersion in otherwise healthy children. We prospectively reviewed 283 patients who were referred to pediatric cardiology department for cardiac evaluation due to murmurs and who were found to have no structural heart disease. The patients were divided into three groups according to their ferritin levels: Group 1: ferritin <15 ng/mL (n = 58); Group 2: ferritin 15–25 ng/mL (n = 80); Group 3: ferritin >25 ng/mL (n = 145). P wave duration (PW), QT and Tp-e intervals, and PW, QT, corrected QT (QTc), and Tp-e dispersions were significantly higher in patients whose ferritin level was <15 ng/mL. A negative correlation was found between ferritin level and QT and QTc intervals, and QT, QTc, and Tp-e dispersions. Our results showed that a low serum ferritin level is associated with changes in some ECG parameters such as prolonged PWd, Tp-e interval, QT, QTc, and Tp-e dispersions in otherwise healthy children, and studies of other populations indicated that these parameters may predict arrhythmias in selected patients. These patients may be considered at some risk of developing arrhythmias. Therefore, careful evaluation of these ECG parameters is necessary in otherwise healthy children with low iron stores.
KeywordsAnemia Ferritin Iron deficiency Tp-e interval Tp-e dispersion
No external funding was used for this manuscript.
Compliance with Ethical Standards
Conflict of interest
The authors declare no conflict of interest.
- 6.Turner LR, Premo DA, Gibbs BJ, Hearthway ML, Motsko M, Sappington A, Walker L, Mullendore ME, Chew HG Jr (2002) Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta blockade on cardiac hypertrophy. BMC Physiol 2:1–10CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Bluzaite I, Brazdzionyte J, Zaliunas R, Rickli H, Ammann P (2006) QT dispersion and heart rate variability in sudden death risk stratification in patients with ischemic heart disease. Med Kaunas 42:450–454Google Scholar
- 22.Castro Hevia J, Antzelevitch C, TornesBarzaga F, Dorantes Sanchez M, DorticosBalea F, Zayas Molina R, Quiñones Pérez MA, Fayad Rodríguez Y (2006) Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 47:1828–1834CrossRefPubMedGoogle Scholar
- 23.Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K, Itoh H, Iwaki T, Oe K, Konno T, Mabuchi H (2002) T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 25:335–339CrossRefPubMedGoogle Scholar
- 26.Bazett HC (1920) An analysis of the time relations of electrocardiograms. Heart 7:353–370Google Scholar
- 33.Haarmark C, Hansen PR, Vedel-Larsen E, Pedersen SH, Graff C, Andersen MP, Toft E, Wang F, Struijk JJ, Kanters JK (2009) The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol 42:555–560CrossRefPubMedGoogle Scholar
- 36.Yildiz M, Aygin D, Pazarli P, Sayan A, Semiz O, Kahyaoglu O, Yildiz BS, Hasdemir H, Akin I, Keser N, Altinkaynak S (2011) Assessment of resting electrocardiogram, P wave dispersion and duration in different genders applying for registration to the School of Physical Education and Sports: results of a single centre Turkish Trial with 2093 healthy subjects. Cardiol Young 21:545–550CrossRefPubMedGoogle Scholar
- 37.Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P (2008) Effect of intravenous iron sucrose on exercise tolerance in anemic and non anemicpatients with symptomatic chronic heart failure and iron deficiency FERRICHF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51:103–112CrossRefPubMedGoogle Scholar